AI Article Synopsis

  • * Low pH negatively impacted photosynthesis by impairing light reaction and carbon fixation, leading to reduced carbon metabolism and ATP production, while some adaptive responses to phosphate and oxidative stress were observed.
  • * Although low pH prompted certain antioxidant responses and gene expressions to mitigate damage, it ultimately disrupted the balance of reactive oxygen species, resulting in oxidative stress and potential damage to the leaves.

Article Abstract

Low pH-induced alterations in gene expression profiles and organic acids (OA) and free amino acid (FAA) abundances were investigated in sweet orange [ (L.) Osbeck cv. Xuegan] leaves. We identified 503 downregulated and 349 upregulated genes in low pH-treated leaves. Further analysis indicated that low pH impaired light reaction and carbon fixation in photosynthetic organisms, thereby lowering photosynthesis in leaves. Low pH reduced carbon and carbohydrate metabolisms, OA biosynthesis and ATP production in leaves. Low pH downregulated the biosynthesis of nitrogen compounds, proteins, and FAAs in leaves, which might be conducive to maintaining energy homeostasis during ATP deprivation. Low pH-treated leaves displayed some adaptive responses to phosphate starvation, including phosphate recycling, lipid remodeling, and phosphate transport, thus enhancing leaf acid-tolerance. Low pH upregulated the expression of some reactive oxygen species (ROS) and aldehyde detoxifying enzyme (peroxidase and superoxidase) genes and the concentrations of some antioxidants (L-tryptophan, L-proline, nicotinic acid, pantothenic acid, and pyroglutamic acid), but it impaired the pentose phosphate pathway and V and secondary metabolite biosynthesis and downregulated the expression of some ROS and aldehyde detoxifying enzyme (ascorbate peroxidase, aldo-keto reductase, and 2-alkenal reductase) genes and the concentrations of some antioxidants (pyridoxine and γ-aminobutyric acid), thus disturbing the balance between production and detoxification of ROS and aldehydes and causing oxidative damage to leaves.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142915PMC
http://dx.doi.org/10.3390/ijms23105844DOI Listing

Publication Analysis

Top Keywords

leaves
8
low
8
low ph-treated
8
ph-treated leaves
8
leaves low
8
ros aldehyde
8
aldehyde detoxifying
8
detoxifying enzyme
8
genes concentrations
8
concentrations antioxidants
8

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA, USA.

Background: Participant dropout from study treatment in a clinical trial can leave a trial underpowered, produce bias in statistical analysis, and limit interpretability of study results. Retaining participants in clinical trials for the full study duration is therefore as important as participant recruitment. This analysis aims to identify the baseline characteristics of participants who discontinued during the blinded phase of one of the first and largest preclinical AD trial completed to date, the Anti-Amyloid treatment in Asymptomatic AD (A4) Study.

View Article and Find Full Text PDF

Background: Current research around caregiving for person's with dementia (PWD) has historically emphasized caregiver burden. This leaves a gap of knowledge around other contributors to caregiving's long-term effects, including grief. The current analysis explores the relationship between caregiver grief and quality-of-life.

View Article and Find Full Text PDF

Background: Adults with comorbidity of cognitive impairment and diabetes is common (19.9%-45.0%) and increasing; however, the evidence is lacking on non-pharmacological behavioral interventions to support cognitive health and diabetes management for individuals with both conditions.

View Article and Find Full Text PDF

Dementia Care Practice.

Alzheimers Dement

December 2024

Lighthouse Health, Inc., New Rochelle, NY, USA.

Japan's aging demographic is witnessing a sharp rise in dementia cases, projected to reach 7.3 million by 2025 and 9.66 million by 2045.

View Article and Find Full Text PDF

Background: Dementia is a progressive clinical syndrome which is marked by pervasive cognitive impairment and deterioration. With the ever-increasing number of people living with dementia, it has become a global concern. Current medications focus on slowing the progression of dementia and managing the comorbidities and not on directly enhancing memory.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!